Medicare Enrolled
Dr. Ronald Vanderlaan, MD
Cardiovascular Disease · Grand Rapids, MI
Practice pattern: Cardiac Imaging
— Practice with significant diagnostic imaging and stress testing
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Vanderlaan from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Vanderlaan?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Vanderlaan
Dr. Ronald Vanderlaan is a cardiovascular disease specialist in Grand Rapids, MI, with 20 years of NPI registration. Based on federal Medicare data, Dr. Vanderlaan performed 1,802 Medicare services across 1,366 unique beneficiaries.
Between the years covered by Open Payments, Dr. Vanderlaan received a total of $13,495 from 51 pharmaceutical and/or device companies across 726 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in cardiovascular disease. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Vanderlaan is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years in practice
▲ Top 34% volume in MI
$13,495 industry payments
Medicare Practice Summary
Medicare Utilization ↗1,802
Medicare services
Top 34% in MI for cardiovascular disease
1,366
Unique beneficiaries
$78
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~90 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
458 | $85 | $150 |
| Electrocardiogram (EKG), 12-lead A standard heart rhythm test using at least 12 leads to record electrical activity. A healthcare provider interprets the results and provides a written report. |
245 | $9 | $35 |
| Regadenoson injection (Lexiscan) for heart stress test An injection of regadenoson, a medication used to stress the heart during diagnostic testing. |
244 | $38 | $75 |
| Echocardiogram, transthoracic An ultrasound of the heart that uses color to show blood flow, rate, direction, and valve function. |
212 | $138 | $415 |
| Technetium Tc-99m sestamibi diagnostic injection A diagnostic injection of technetium Tc-99m sestamibi used for imaging studies. |
144 | $108 | $325 |
| Exercise or drug-induced heart stress test with ECG A heart stress test performed using exercise or medication while monitoring the electrocardiogram under physician supervision and review. |
76 | $46 | $150 |
| Nuclear stress test of heart muscle A nuclear medicine imaging test that evaluates blood flow to the heart muscle at rest and during stress using a special camera. |
72 | $309 | $900 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
58 | $98 | $200 |
| External EKG monitoring, 8-15 days Continuous external electrocardiogram recording and review over a period of 8 to 15 days to monitor heart rhythm. |
37 | $20 | $66 |
| Ultrasound of head and neck blood flow, bilateral An ultrasound exam that uses sound waves to visualize and assess blood flow in the vessels of both the head and the neck. |
31 | $132 | $350 |
| Echocardiogram, transthoracic An ultrasound test that uses sound waves to create images of the heart's blood flow, valves, and chambers. |
30 | $34 | $125 |
| Echocardiogram with color Doppler An ultrasound of the heart that uses color imaging to visualize blood flow, measure flow rate, and assess valve function. |
30 | $16 | $150 |
| Stress echocardiogram with ECG monitoring An ultrasound of the heart performed while monitoring heart rhythm during rest, exercise, or medication-induced stress, followed by a review and report of the findings. |
30 | $162 | $500 |
| Continuous external EKG monitoring, 48 hours to 7 days This procedure involves recording the heart's electrical activity continuously using an external device for a period exceeding 48 hours but not more than 7 days. |
29 | $8 | $35 |
| Continuous EKG monitoring review, 48-7 days Review and interpretation of continuous external EKG recordings lasting more than 48 hours up to 7 days. |
28 | $17 | $60 |
| Continuous external EKG monitoring, 8-15 days This procedure involves recording heart rhythm continuously using an external EKG device over a period of 8 to 15 days. |
28 | $7 | $35 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
24 | $9 | $18 |
| Telephone medical discussion, 11-20 minutes A phone conversation with a physician lasting between 11 and 20 minutes. |
15 | $41 | $180 |
| Injection, dobutamine hydrochloride, per 250 mg | 11 | $6 | $100 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
13.4% high complexity
36.7% medium
49.8% routine
Industry Payment Transparency
Open Payments through 2024 ↗$13,495
Total received (2018-2024)
Avg $1,928/year across 7 years
Top 20% in MI for cardiovascular disease
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
51
Companies
726
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$13,495 (100.0%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$2,647
2023
$2,363
2022
$2,599
2021
$1,528
2020
$1,255
2019
$1,713
2018
$1,388
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Amgen Inc.
$553
AstraZeneca Pharmaceuticals LP
$255
Bayer Healthcare Pharmaceuticals Inc.
$165
PFIZER INC.
$161
Merck Sharp & Dohme LLC
$160
Kiniksa Pharmaceuticals International, plc
$153
Boehringer Ingelheim Pharmaceuticals, Inc.
$145
E.R. Squibb & Sons, L.L.C.
$141
Alnylam Pharmaceuticals Inc.
$138
Novo Nordisk Inc
$130
Lexicon Pharmaceuticals, Inc.
$100
Novartis Pharmaceuticals Corporation
$83
Janssen Pharmaceuticals, Inc
$77
Vital Connect, Inc
$67
Cleerly, Inc.
$66
Esperion Therapeutics, Inc.
$61
Boston Scientific Corporation
$51
Inspire Medical Systems, Inc.
$33
Baxter Healthcare
$31
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)
$22
Daiichi Sankyo Inc.
$20
HEARTFLOW, INC.
$18
ABIOMED
$18
Top 3 companies account for 36.7% of 2024 payments
All-time payments by company (2018-2024) ›
AstraZeneca Pharmaceuticals LP
$1,382
Amgen Inc.
$1,311
Novartis Pharmaceuticals Corporation
$872
Amarin Pharma Inc.
$851
Janssen Pharmaceuticals, Inc
$846
PFIZER INC.
$720
Boehringer Ingelheim Pharmaceuticals, Inc.
$593
Alnylam Pharmaceuticals Inc.
$584
Merck Sharp & Dohme LLC
$571
Bayer Healthcare Pharmaceuticals Inc.
$544
Novo Nordisk Inc
$498
E.R. Squibb & Sons, L.L.C.
$448
Bayer HealthCare Pharmaceuticals Inc.
$406
Boston Scientific Corporation
$366
Daiichi Sankyo Inc.
$282
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)
$257
Esperion Therapeutics, Inc.
$251
Actelion Pharmaceuticals US, Inc.
$189
Gilead Sciences, Inc.
$164
Abbott Laboratories
$163
Merck Sharp & Dohme Corporation
$160
iRhythm Technologies, Inc.
$159
Kiniksa Pharmaceuticals, Ltd.
$154
Kiniksa Pharmaceuticals International, plc
$153
Lundbeck LLC
$141
Kowa Pharmaceuticals America, Inc.
$138
SANOFI-AVENTIS U.S. LLC
$134
Lexicon Pharmaceuticals, Inc.
$134
BOSTON SCIENTIFIC CORPORATION
$109
Astellas Pharma US Inc
$107
Regeneron Healthcare Solutions, Inc.
$93
Bardy Diagnostics, Inc.
$83
Vital Connect, Inc
$67
Cleerly, Inc.
$66
GENZYME CORPORATION
$65
Baxter Healthcare
$63
ARBOR PHARMACEUTICALS, INC.
$38
Akcea Therapeutics, Inc.
$34
ABIOMED
$34
Inspire Medical Systems, Inc.
$33
GE HEALTHCARE
$32
Arbor Pharmaceuticals, Inc.
$29
Chiesi USA, Inc.
$25
Otsuka America Pharmaceutical, Inc.
$24
MEDLINE INDUSTRIES LP
$21
MEDICOMP INC
$20
ATRICURE, INC.
$19
HEARTFLOW, INC.
$18
Sobi, Inc
$18
Braemar Manufacturing, LLC
$15
BIOTRONIK INC.
$14
Top 3 companies account for 26.4% of all-time payments
Associated products mentioned in payments ›
AMVUTTRA · Arcalyst · BIOMONITOR · BRILINTA · CAMZYOS · CHANTIX · CLEVIPREX · CONFIRM RX · Cardiac Monitor · Cardiac Monitoring Suite · CardioMEMS HF System · Carnation Ambulatory Monitor · Cleerly Labs · Corlanor · ELIQUIS · ENTRESTO · EPI-SENSE GUIDED COAGULATION SYSTEM WITH VISITRAX · EVKEEZA · Edarbi · Edarbyclor · FABRAZYME · FABRY-DISEASE · FARXIGA · FFRct · GILENYA · HeartMate 3 Left Ventricular Dev · Hillrom - Cardiac Ambulatory Monitor · INJECTAFER · INSPIRE · Impella · Inpefa · JARDIANCE · Kerendia · LEQVIO · LEXISCAN · LifeVest · Livalo · MULTAQ · NEXLETOL · NEXLIZET · NORTHERA · ONFI · ONPATTRO · OPSUMIT · OPSUMIT MACITENTAN · Ozempic · PRADAXA · PRALUENT · PRALUENT ALIROCUMAB INJECTION · Ranexa · Repatha · Rybelsus · SAMSCA · TEGSEDI · UPTRAVI · VALITUDE · VERQUVO · VITALPATCH RTM · VYNDAQEL · Vascepa · WAINUA · WATCHMAN · WATCHMAN Access System · WATCHMAN FLX · WINREVAIR · Wegovy · XARELTO · ZIO Patch · ZIO XT Patch
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Cardiologists within 10 mi
64
Per 100K population
9.7
County median income
$80,390
Nearest hospital
FOREST VIEW PSYCHIATRIC HOSPITAL
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Vanderlaan is a cardiac imaging specialist, with moderate Medicare volume, with low-engagement industry engagement in the top 20% of MI peers, with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Vanderlaan experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Vanderlaan performed 458 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Vanderlaan receive payments from pharmaceutical companies?
Yes. Dr. Vanderlaan received a total of $13,495 from 51 companies across 726 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Vanderlaan's costs compare to other cardiologists in Grand Rapids?
Dr. Vanderlaan's average Medicare payment per service is $78. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Vanderlaan) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Cardiologists in Grand Rapids
Browse cardiologists in Grand Rapids ranked by procedure volume and transparency data.
Highest volume
Top Cardiologists in MI
Cardiologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Cardiologists in MI
Which MI cardiologists receive the most from drug and device companies.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
By company
Amgen Inc. Payments to Doctors
See all physicians who received payments from Amgen Inc.
By company
Novartis Pharmaceuticals Corporation Payments to Doctors
See all physicians who received payments from Novartis Pharmaceuticals Corporation.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology